Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial

Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R.

J Clin Oncol. 2010 Feb 20;28(6):967-75. Epub 2010 Jan 11.

PMID: 20065185 [PubMed – indexed for MEDLINE]